Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Changbao Chen 1,* , Meng Zhao 2,* , Aixian Tian 3 , Xiaolin Zhang 1 , Zhi Yao 2 and Xinlong Ma 1 1 Department of Spinal Surgery, Tianjin Hospital, Tianjin, P. R. China 2 Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Educational Ministry of China, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, P. R. China 3 Department of Medical Laboratory, Tianjin Hospital, Tianjin, P. R. China * These authors have contributed equally to this work Correspondence to: Xinlong Ma, email: // Zhi Yao, email: // Keywords : bone sarcomas; Wnt/β-catenin signaling; autocrine wnt activation; cell proliferation; therapeutic target Received : October 09, 2014 Accepted : March 30, 2015 Published : May 11, 2015 Abstract Bone sarcomas such as osteosarcoma and chondrosarcoma are frequently refractory to conventional chemotherapy and radiotherapy that exhibit poor prognosis. The Wnt signaling are evolutionarily conserved and implicated in cell proliferation and sarcomagenesis. However, the potential role of the Wnt signaling in bone sarcomas is still unclear. Here we demonstrate aberrant activation of Wnt/β-catenin signaling in bone sarcoma cells, involving an autocrine Wnt signaling loop with upregulation of specific Wnt ligands and receptors. Activation of Wnt/β-catenin signaling with Wnt3a or GSK-3β inhibitor drives the proliferation of bone sarcoma cells, whereas downregulation of activated Wnt signaling with dnTCF4 or siLEF1 suppresses bone sarcoma proliferation and induces cell cycle arrest. Taken together, our findings establish the evidence that aberrant activation of Wnt/β-catenin pathway involving an autocrine Wnt singaling drives the proliferation of bone sarcoma cells, and identify the autocrine activation of the Wnt/β-catenin signaling as a potential novel therapeutic target for bone sarcomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183 · cited 2×
“Abnormalities in Wnt signaling are implicated in a variety of human tumors by mechanisms such as inactivating aberrations of APC, CTNNB1, or Axin1 (deletion) [17, 18, 19], and through autocrine Wnt signaling recently recognized [20-22].”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482 · cited 2×
“Abnormalities in Wnt signaling are implicated in a variety of human tumors by mechanisms such as inactivating aberrations of APC, CTNNB1, or Axin1 (deletion) [17, 18, 19], and through autocrine Wnt signaling recently recognized [20-22].”
BackgroundNovel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Bafico, A., Liu, G., Yaniv, A., Gazit, A., & Aaronson, S. A. (2001) · Nature Cell Biology · doi:10.1038/35083081 · Cited by 772
Khan, Z., Vijayakumar, S., de la Torre, T. V., Rotolo, S., & Bafico, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00773-07 · Cited by 73 · cited 1×
“Intriguingly, the Wnt signaling is intricately regulated at multiple levels through receptor modulation [10], and feedback-negative regulators such as Axin2 and DKK1 [9, 11].”
Background
Cited by
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382
“Numerous studies have demonstrated that dysregulated activation of the canonical Wnt signaling pathway contributes to both the development and metastasis of OS [268, 269].”
BackgroundWnt Pathway in Bone Repair and Regeneration – What Do We Know So Far
Houschyar, K. S., Tapking, C., Borrelli, M. R., Popp, D., Duscher, D., Maan, Z. N., Chelliah, M. P., Li, J., Harati, K., Wallner, C., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00170 · Cited by 295
Mediator Condensates Localize Signaling Factors to Key Cell Identity Genes
Zamudio, A. V., Dall’Agnese, A., Henninger, J. E., Manteiga, J. C., Afeyan, L. K., Hannett, N. M., Coffey, E. L., Li, C. H., Oksuz, O., Sabari, B. R., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.08.016 · Cited by 283
Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy
Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G. E., Santucci, A., Vermi, W., & Giurisato, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155207 · Cited by 280
“The Wnt/ β-catenin-signaling pathway is markedly upregulated in OS and plays a pivotal role in tumorigenesis [28,29] and metastases [30].”
BackgroundMartins-Neves, S. R., Paiva-Oliveira, D. I., Fontes-Ribeiro, C., Bovée, J. V. M. G., Cleton-Jansen, A.-M., & Gomes, C. M. F. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.004 · Cited by 115
Metadata
- Authors
- Chen, C., Zhao, M., Tian, A., Zhang, X., Yao, Z., & Ma, X.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-05-11
- Volume
- 6
- Issue
- 19
- Pages
- 17570-17583
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1558726597
- Cited by
- 92
- References
- 6
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells. https://app.cochat.ai/papers/10.18632/oncotarget.4100
- The paper
- Chen, C., Zhao, M., Tian, A., Zhang, X., Yao, Z., & Ma, X. (2015). Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells. Oncotarget. https://doi.org/10.18632/oncotarget.4100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.